Clovis Oncology Inc. said it appointed Robert Azelby and Richard Fair to the company's board of directors.

Azelby has been serving as the president, CEO and director of Alder Biopharmaceuticals Inc. since June.

Fair has worked as president, CEO and a board member of Bellicum Pharmaceuticals Inc. since January 2017.

Boulder, Colo.-based Clovis Oncology is a biopharmaceutical company focused on developing anti-cancer agents.